In what is described as the largest foreign takeover by a Japanese company, drug maker Takeda's $62 billion purchase of Shire Plc is now complete. The two companies generate a combined $30 billion annual revenue. Under the deal, Takeda acquired Shire's recently-opened $1 billion immunoglobulin plasma fractionation plant in Covington, Georgia. The company is the site's fourth owner, having changed hands three other times since construction began in 2013.
/iirenergy/industry-news/article.jsp
Want More IIR News?
Make us a Preferred Source on Google to see more of us when you search.
Add Us On Google
Loading...
Refer This Article
Ask Us
Have a question for our staff?
Submit a question and one of our experts will be happy to assist you.
Explore Our EnergyLive Tools
EnergyLive Tools provide instant insight into new build, outages, maintenance, and capacity shifts across key energy sectors.
Learn MoreRelated Articles
-
Life-Science New Build Report: 200 North American Sites in P...November 04, 2014
-
Pharma-Biotech Industry Capital Investment Tops $12 Billion ...January 14, 2014
Explore Our Enery Industry Reports
Gain the competitive edge with IIR Energy’s suite of energy market reports, designed for traders, analysts, and asset managers who rely on verified, real-time data.
Learn MoreIndustry Intel
-
From Data to Decisions: How IIR Energy Helps Navigate Market VolatilityOn-Demand Podcast / Nov. 18, 2025
-
Navigating the Hydrogen Horizon: Trends in Blue and Green EnergyOn-Demand Podcast / Nov. 3, 2025
-
ESG Trends & Challenges in Latin AmericaOn-Demand Podcast / Nov. 3, 2025
-
2025 European Transportation & Biofuels Spending OutlookOn-Demand Podcast / Oct. 27, 2025
-
2025 Global Oil & Gas Project Spending OutlookOn-Demand Podcast / Oct. 24, 2025